Tag: Icahn School of Medicine at Mount Sinai
New Blood Test Accurately Determines the Threshold Dose for Reactions to...
Allergenis’ bead-based epitope assay is a breakthrough diagnostic for peanut allergy.
Epinephrine Remains Alarmingly Underused for Anaphylaxis in Children: Study
The use of epinephrine — the treatment of choice for anaphylaxis — remains at suboptimal levels.
AllerGenis Lauds Study Results of New, More Accurate Blood Test for...
"Test brings us one step closer to eliminating the need to subject patients to an oral food challenge."
Artificial Food Colorants Can Cause Disease After Immune System Dysregulation
When given a diet with the food dyes Red 40 or Yellow 6, the altered mice developed IBD.
NIH Study of Early Predictors, Mechanisms of Food Allergy and Eczema...
Study to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis as well as biological pathways that lead to these conditions.
Egg Oral Immunotherapy Could be Better Option than Baked Egg Therapy...
5 year multi-site study shows egg OIT was significantly more likely to achieve sustained unresponsiveness compared to children opting for baked egg therapy.
Multi-omics Approach Offers New Insights into Peanut Allergy Severity
Findings could improve diagnostics and lead to new treatments.
Mount Sinai Researchers Find Wheat Oral Immunotherapy to Be Therapeutic for...
First multicenter rigorous clinical trial yields promising results.
DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy
"This submission represents a significant step forward for those families living with peanut allergy."
Study: Researchers Identify Six Genes Driving Peanut Allergy Reactions
Results represent important step forward for new therapies and treatments.
